Clinical Trial Update: To Evaluate the Pharmacokinetics and Safety of TQD3606 for Injection in Subjects With Renal Insufficiency [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics and safety of TQD3606 for injection in subjects with renal insufficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Insufficiency

Drugs mentioned

• TQD3606

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Resistant to Gram-positive, Gram-negative and Anaerobic Bacteria | Phase 1 | Status: COMPLETED